🚑 Aprea Therapeutics, a Swedish developer of oncology drugs, raised $85 million in its IPO. The pre-revenue company priced 5.7 million shares at $125 (middle of range), for an initial market cap of $288 million. It will trade on the Nasdaq (APRE), used J.P. Morgan as lead underwriter, and had raised around $125 million in VC funding from 5AM Ventures (17.73% pre-IPO stake), Versant Ventures (17.73%), Karolinska Development (17.21%), HealthCap (14.77%), Redmile Group (13.15%), and Sectoral Asset Management (10.35%).
🚑 Frequency Therapeutics, a Woburn, Mass.-based drug-maker focused on hearing loss, raised $84 million in its IPO. The pre-revenue company sold 6 million shares at $14, versus plans to sell 6.7 million at $14-$16. It will trade on the Nasdaq (FREQ), used J.P. Morgan as lead underwriter, and had raised nearly $150 million in VC funding from Perceptive Advisors (7.7% pre-IPO stake), Taiwania Capital (5.7%), Deerfield Management, RTW Investments, Mizuho Securities, Polaris Founders Capital, Axil Capital, and CoBro Ventures.
• MetroCity Bankshares, a Doraville, Ga.-based bank with 19 branches, raised $26 million in its IPO. The company priced 1.94 million shares at $13.50 (below range), for an initial market cap of $342 million. It will trade on the Nasdaq (MCBS), and used Keefe Bruyette Woods as lead underwriter.
🚑 Monopar Therapeutics, a Wilmette, Ill.-based developer of therapeutics for cancer and the side effects of chemotherapy, postponed its planned $40 million IPO, citing market conditions. The pre-revenue company planned to trade on the Nasdaq (MNPR) with JonesTrading as lead underwriter.
• Topsports, a Chinese sportswear maker, raised US$1.01 billion in a Hong Kong IPO. http://axios.link/0pcc
🚑 Viela Bio, a Gaithersburg, Md.-based inflammation and autoimmune biotech, raised $150 million in its IPO. It priced 7.9 million shares at $19, versus plans to offer 7.5 million shares at $19-$21, and will trade on the Nasdaq (VIE). Goldman Sachs was lead underwriter. Viela spun out of AstraZeneca in 2017 and raised $250 million in Series A funding from 6 Dimensions Capital, Boyu Capital, Hillhouse Capital, Temasek, and Sirona Capital.